It is with great regret that we inform you of the passing of William Frankland, MBE at the age of 108. The world-renowned British allergist contributed greatly to progress in our field, including the first controlled clinical trial of allergen immunotherapy, which demonstrated its efficacy (published in 1954), and the development of pollen counting in 1953 and its subsequent popularisation as a regular piece of weather-related information to the public. In June 2015, at the age of 103, he was made a Member of the Order of the British Empire (MBE) for his service to allergy. Well past his 100th birthday, he continued to write for medical journals, attend international scientific conferences and make media appearances, imparting his knowledge and wisdom, and portraying the truly impressive dedication and passion he had for our field of medicine. It was a great privilege for our Academy that Bill Frankland was EAACI president from 1977 to 1980. An inspiration to all of us, he will be sorely missed. The entire EAACI Family extends their deepest condolences to his family and friends.
Last updated 03 April 2020
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback